Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search

Commentary

 

Aug 23 2017

FDA’s Approval of High-Risk Medical Devices

By Kevin Roche Commentary No Comments
A study in JAMA suggests that the FDA's review of high-risk medical devices hasn't been as thorough as it should be.
Read More
Aug 22 2017

A Solar Eclipse Journey

By Kevin Roche Commentary No Comments
The solar eclipse was fascinating, but a road trip through America's heartland is more enlightening.
Read More
Aug 21 2017

The Cost of Health Insurance Expansions

By Kevin Roche Commentary No Comments
Happy eclipse day!! A recent commentary in the New England Journal of Medicine exaggerates the benefits and minimizes the costs of health insurance expansions.
Read More
Aug 16 2017

More from the MedPAC Report On Health Spending

By Kevin Roche Commentary No Comments
More insights from the MedPAC report on national health spending and Medicare.
Read More
Aug 15 2017

MedPAC Report on Health Spending and Medicare

By Kevin Roche Commentary No Comments
The Medicare Payment Advisory Commission issues a report on health spending and the Medicare program.
Read More
Aug 14 2017

Physician Group Practice Data

By Kevin Roche Commentary No Comments
The American Medical Group Association and the Medical Group Management Association release some information regarding costs and compensation for medical practices.
Read More
Aug 10 2017

Price and the Demand for Health Services

By Kevin Roche Commentary No Comments
New research carried in the Journal of Health Economics describes the price elasticity of demand for health care services.
Read More
Aug 09 2017

The Persistence of High-Deductible Plan Spending Reductions

By Kevin Roche Commentary No Comments
Recent research suggests that high-deductible plans result in reduced spending over at least a three year time frame.
Read More
Aug 08 2017

The Costs of Developing Prescription Medications

By Kevin Roche Commentary No Comments
Research in the Journal of Health Economics estimates the costs of developing a new medication.
Read More
Aug 07 2017

Medicaid Disease Management

By Kevin Roche Commentary No Comments
A study in the Journal of Health Economics once again indicates that disease management programs have a hard time creating spending reductions that cover the cost of the program.
Read More
  • « Previous
  • 1
  • …
  • 405
  • 406
  • 407
  • 408
  • 409
  • …
  • 623
  • Next »

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

Angle Health, a vendor of a supposedly artificial intelligence powered health benefits platform for employers raised $134 million in new capital.  All you have to do is mention AI and...
December 4, 2025
Reema Health, which calls itself a complex care management company, reamed investors for $19 million in capital, to be used for the usual “to support growth”.  The firm works with...
December 2, 2025
Press Ganey, which provides market research for health plans and providers , is being purchased by health care survey firm Qualtrics for $6.75 billion.  Both companies claim this is all...
October 6, 2025
Another weirdly named company, Thyme Care, spices things up by raising a fresh $97 million in capital to support its cancer care managment business.
September 25, 2025

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1843) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Health Affairs
  • Congressional Budget Office

RSS Feed

RSS feed

© 2025 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts